Sinovac Receives Competing Non-Binding "Going Private" Proposal of $7.00/Share in Cash

By: via Benzinga
Sinovac Biotech Ltd. (NASDAQ: SVA) today announced that the special committee of its board of directors received on February 4, 2016 a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.